These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28859296)

  • 21. Updated perspectives on vascular cell specification and pluripotent stem cell-derived vascular organoids for studying vasculopathies.
    Liu C; Niu K; Xiao Q
    Cardiovasc Res; 2022 Jan; 118(1):97-114. PubMed ID: 33135070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in situ collagen-HA hydrogel system promotes survival and preserves the proangiogenic secretion of hiPSC-derived vascular smooth muscle cells.
    Dash BC; Duan K; Xing H; Kyriakides TR; Hsia HC
    Biotechnol Bioeng; 2020 Dec; 117(12):3912-3923. PubMed ID: 32770746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication of a myocardial patch with cells differentiated from human-induced pluripotent stem cells.
    Ye L; Basu J; Zhang J
    Methods Mol Biol; 2015; 1299():103-14. PubMed ID: 25836578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages.
    Masumoto H; Nakane T; Tinney JP; Yuan F; Ye F; Kowalski WJ; Minakata K; Sakata R; Yamashita JK; Keller BB
    Sci Rep; 2016 Jul; 6():29933. PubMed ID: 27435115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics.
    Biel NM; Santostefano KE; DiVita BB; El Rouby N; Carrasquilla SD; Simmons C; Nakanishi M; Cooper-DeHoff RM; Johnson JA; Terada N
    Stem Cells Transl Med; 2015 Dec; 4(12):1380-90. PubMed ID: 26494780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
    Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
    Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future application of induced pluripotent stem cells in vascular regenerative medicine.
    Religa P
    Cardiovasc Res; 2012 Dec; 96(3):348-9. PubMed ID: 23090608
    [No Abstract]   [Full Text] [Related]  

  • 29. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
    Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
    Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Mechanical Stimuli on the Phenotypic Plasticity of Induced Pluripotent Stem-Cell-Derived Vascular Smooth Muscle Cells in a 3D Hydrogel.
    Meijer EM; Giles R; van Dijk CGM; Maringanti R; Wissing TB; Appels Y; Chrifi I; Crielaard H; Verhaar MC; Smits AIPM; Cheng C
    ACS Appl Bio Mater; 2023 Dec; 6(12):5716-5729. PubMed ID: 38032545
    [No Abstract]   [Full Text] [Related]  

  • 32. Three-Dimensional Vessels-on-a-Chip Based on hiPSC-derived Vascular Endothelial and Smooth Muscle Cells.
    Bulut M; Vila Cuenca M; de Graaf M; van den Hil FE; Mummery CL; Orlova VV
    Curr Protoc; 2022 Oct; 2(10):e564. PubMed ID: 36250774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia facilitates proliferation of smooth muscle cells derived from pluripotent stem cells for vascular tissue engineering.
    Fang L; Mei J; Yao B; Liu J; Liu P; Wang X; Zhou J; Lin Z
    J Tissue Eng Regen Med; 2022 Aug; 16(8):744-756. PubMed ID: 35633489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of Cylindrical Engineered Cardiac Tissues from Human iPS Cell-Derived Cardiovascular Cell Lineages.
    Masumoto H
    Methods Mol Biol; 2021; 2320():81-88. PubMed ID: 34302650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation, expansion, and differentiation of cardiovascular progenitor cells from human pluripotent stem cells.
    Cao N; Liang H; Yang HT
    Methods Mol Biol; 2015; 1212():113-25. PubMed ID: 25208753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation).
    Kane NM; Xiao Q; Baker AH; Luo Z; Xu Q; Emanueli C
    Pharmacol Ther; 2011 Jan; 129(1):29-49. PubMed ID: 20965210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
    Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
    Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation.
    Cheung C; Sinha S
    J Mol Cell Cardiol; 2011 Nov; 51(5):651-64. PubMed ID: 21816157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac Adipose-Derived Stem Cells Exhibit High Differentiation Potential to Cardiovascular Cells in C57BL/6 Mice.
    Nagata H; Ii M; Kohbayashi E; Hoshiga M; Hanafusa T; Asahi M
    Stem Cells Transl Med; 2016 Feb; 5(2):141-51. PubMed ID: 26683873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.